|
|
| [PMID]: | 23185266 | | [Au] Autor: | Prisby RD; Dominguez JM; Muller-Delp J; Allen MR; Delp MD |
| [Ad] Address: | Department of Kinesiology and Applied Physiology, University of Delaware, Newark, DE, USA. | | [Ti] Title: | Aging and estrogen status: a possible endothelium-dependent vascular coupling mechanism in bone remodeling. | | [So] Source: | PLoS One;7(11):e48564, 2012. | | [Is] ISSN: | 1932-6203 | | [Cp] Country of publication: | United States | | [La] Language: | eng | | [Ab] Abstract: | Bone loss with aging and menopause may be linked to vascular endothelial dysfunction. The purpose of the study was to determine whether putative modifications in endothelium-dependent vasodilation of the principal nutrient artery (PNA) of the femur are associated with changes in trabecular bone volume (BV/TV) with altered estrogen status in young (6 mon) and old (24 mon) female Fischer-344 rats. Animals were divided into 6 groups: 1) young intact, 2) old intact, 3) young ovariectomized (OVX), 4) old OVX, 5) young OVX plus estrogen replacement (OVX+E2), and 6) old OVX+E2. PNA endothelium-dependent vasodilation was assessed in vitro using acetylcholine. Trabecular bone volume of the distal femoral metaphysis was determined by microCT. In young rats, vasodilation was diminished by OVX and restored with estrogen replacement (intact, 82±7; OVX, 61±9; OVX+E2, 90±4%), which corresponded with similar modifications in BV/TV (intact, 28.7±1.6; OVX, 16.3±0.9; OVX+E2, 25.7±1.4%). In old animals, vasodilation was unaffected by OVX but enhanced with estrogen replacement (intact, 55±8; OVX, 59±7; OVX+E2, 92±4%). Likewise, modifications in BV/TV followed the same pattern (intact, 33.1±1.6; OVX, 34.4±3.7; OVX+E2, 42.4±2.1%). Furthermore, in old animals with low endogenous estrogen (i.e., intact and old OVX), vasodilation was correlated with BV/TV (R(2) = 0.630; P<0.001). These data demonstrate parallel effects of estrogen on vascular endothelial function and BV/TV, and provide for a possible coupling mechanism linking endothelium-dependent vasodilation to bone remodeling. |
| [Mh] MeSH terms primary: |
Aging/metabolism Bone Remodeling/physiology Endothelium, Vascular/physiology Estrogens/metabolism
|
| [Mh] MeSH terms secundary: |
Aging/blood Animals Arteries/drug effects Arteries/physiology Bone Remodeling/drug effects Bone and Bones/drug effects Bone and Bones/physiology Cyclooxygenase Inhibitors/pharmacology Endothelium, Vascular/drug effects Enzyme Inhibitors/pharmacology Estrogen Replacement Therapy Estrogens/blood Female Hydrazines/pharmacology NG-Nitroarginine Methyl Ester/pharmacology Nitric Oxide Synthase/antagonists & inhibitors Nitric Oxide Synthase/metabolism Organ Size/drug effects Ovariectomy Rats Rats, Inbred F344 Regression Analysis Vasodilator Agents/pharmacology
|
| [Pt] Publication type: | JOURNAL ARTICLE; RESEARCH SUPPORT, N.I.H., EXTRAMURAL; RESEARCH SUPPORT, NON-U.S. GOV'T; RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S. | | [Nm] Name of substance: | 0 (Cyclooxygenase Inhibitors); 0 (Enzyme Inhibitors); 0 (Estrogens); 0 (Hydrazines); 0 (Vasodilator Agents); 50903-99-6 (NG-Nitroarginine Methyl Ester); 86831-65-4 (1,1-diethyl-2-hydroxy-2-nitrosohydrazine); EC 1.14.13.39 (Nitric Oxide Synthase) | | [Em] Entry month: | 1305 | | [Js] Journal subset: | IM | | [Da] Date of entry for processing: | 121127 | | [St] Status: | MEDLINE |
| [do] DOI: | 10.1371/journal.pone.0048564 |
|